Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 19Thoracic 1Dermatologic 1

Conditions

Lung Neoplasms 102Carcinoma, Non-Small-Cell Lung 84Breast Neoplasms 16Neoplasm Metastasis 14Melanoma 14Brain Neoplasms 14Small Cell Lung Carcinoma 13Esophageal Neoplasms 10Colorectal Neoplasms 9Carcinoma, Renal Cell 9Pancreatic Neoplasms 8Ovarian Neoplasms 8Adenocarcinoma of Lung 8Prostatic Neoplasms 7Carcinoma, Hepatocellular 7Colonic Neoplasms 6Stomach Neoplasms 5Carcinoma, Transitional Cell 5Uterine Cervical Neoplasms 4Triple Negative Breast Neoplasms 4Thyroid Neoplasms 4Sarcoma, Kaposi 4Rectal Neoplasms 4Meningeal Carcinomatosis 4Squamous Cell Carcinoma of Head and Neck 3Neoplasms 3Lymphoma 3Head and Neck Neoplasms 3HIV Infections 3Carcinoma, Medullary 3

Interventions

Carboplatin 24Pemetrexed 18Cisplatin 17Paclitaxel 14pembrolizumab 13Gemcitabine 8osimertinib 7durvalumab 6Docetaxel 6Nivolumab 5Erlotinib Hydrochloride 5130-nm albumin-bound paclitaxel 5capmatinib 3brigatinib 3anlotinib 3Gefitinib 3Drug Therapy 3vosaroxin 2volociximab 2sintilimab 2pralsetinib 2ensartinib 2atezolizumab 2aflibercept 2Surgical Procedures, Operative 2Radiotherapy, Intensity-Modulated 2Radiotherapy 2Radiation 2Oncolytic Virotherapy 2Ipilimumab 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Carcinoma × Magnetic Resonance Spectroscopy × Thoracic × Clear all
NCT00599755 2018-01-16

Phase I Imaging Study Evaluating Gem/Cis or Gem/Carbo for Participants With Non-Small Cell Lung Cancer (MK-0000-083 AM3)

Merck Sharp & Dohme LLC

Phase 1 Completed
68 enrolled 12 charts
Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡